Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Securian Asset Management Inc.

Securian Asset Management Inc. reduced its position in Cardinal Health, Inc. (NYSE:CAH) by 2.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 13,952 shares of the company’s stock after selling 374 shares during the quarter. Securian Asset Management Inc.’s holdings in Cardinal Health were worth $1,372,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Clearstead Trust LLC purchased a new position in shares of Cardinal Health in the 4th quarter worth about $25,000. Raleigh Capital Management Inc. raised its holdings in Cardinal Health by 4,466.7% in the fourth quarter. Raleigh Capital Management Inc. now owns 274 shares of the company’s stock valued at $28,000 after buying an additional 268 shares during the period. YHB Investment Advisors Inc. acquired a new position in Cardinal Health during the first quarter valued at approximately $32,000. LRI Investments LLC purchased a new stake in Cardinal Health during the first quarter worth approximately $32,000. Finally, Palisade Asset Management LLC acquired a new stake in shares of Cardinal Health in the first quarter worth $34,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. StockNews.com lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Thursday. Wells Fargo & Company decreased their target price on Cardinal Health from $96.00 to $94.00 and set an “underweight” rating for the company in a research report on Monday, April 29th. Evercore ISI dropped their target price on Cardinal Health from $115.00 to $105.00 and set an “in-line” rating on the stock in a report on Tuesday, July 9th. Robert W. Baird upped their price target on Cardinal Health from $129.00 to $130.00 and gave the stock an “outperform” rating in a report on Tuesday, July 9th. Finally, Citigroup lowered their price objective on shares of Cardinal Health from $115.00 to $107.00 and set a “neutral” rating for the company in a research report on Friday, July 19th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $109.67.

Cardinal Health Price Performance

NYSE CAH remained flat at $100.67 during trading hours on Monday. 579,746 shares of the company’s stock were exchanged, compared to its average volume of 2,128,632. The stock has a market capitalization of $24.52 billion, a PE ratio of 44.74, a PEG ratio of 1.14 and a beta of 0.61. Cardinal Health, Inc. has a 12-month low of $85.11 and a 12-month high of $116.04. The stock has a 50 day simple moving average of $98.70 and a 200 day simple moving average of $103.21.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.